Skip to main content
Edwards Lifesciences Logo

Acumen intelligent decision support suite

doctor monitor
The Critical Care product group is now part of BD (Becton, Dickinson and Company). Edwards Lifesciences is the manufacturer of the products.

Harnessing the power of machine learning, Acumen suite offers both predictive decision support and retrospective data analysis. With access to advanced hemodynamic monitoring that provides continuous pressure and flow parameters, you will get valuable insight into the adequacy of perfusion.

retrospective data

Acumen suite of software and sensors enable you to:

hypotension icon

Predict the likelihood of hypotension with Acumen Hypotension Prediction Index (HPI) software

fluid icon

Optimize fluid administration with Acumen Assisted Fluid Management (AFM) software

hemosphere icon

Proactively manage hemodynamic instability using machine learning algorithms

Acumen software:
predictive insights, retrospective analysis

Acumen HPI software

relationship view screen

Acumen HPI software is effective in detecting hemodynamic instability and substantially reducing the duration of intraoperative hypotension.

A recent study demonstrated a 57% reduction in the duration of intraoperative hypotension.*1

*Compared to a retrospective historical control group, in noncardiac surgical patients requiring arterial line monitoring

Managing pressure and flow is key to hemodynamic stability

tissue perfusion

Maintaining adequate perfusion

Adequate perfusion requires adequate arterial pressure and cardiac output. Advanced hemodynamic monitoring can provide access to continuous pressure and flow parameters, giving you valuable insight into the adequacy of patient perfusion.

Intraoperative hypotension is common and may elevate risk – but it can be reduced1-4

  • A recent study reported at least one hypotensive event* in 88% of noncardiac cases4
  • Risks of end-organ injury increase with prolonged exposure to MAP 65-60 mmHg or for any exposure <55-50 mmHg3
  • Acumen HPI software demonstrated a 57% reduction in duration of intraoperative hypotension from 28 to 12 minutes1**

*A hypotensive event is defined as MAP <65 mmHg for at least 1 minute.

**Prospective, single-arm, multicenter study in noncardiac surgical patients requiring arterial line monitoring compared to a historical control

Edwards clinical education

Hemodynamic education empowering clinical advancement

Edwards clinical education meets you no matter where you are in the learning process. With a long-term commitment to improving the quality of care for surgical and critical care patients, Edwards’ continuum of educational resources and tools support you as you solve clinical challenges today and in the future.

References

  1. U.S. Food and Drug Administration. 2021. K203224 510k Summary, Acumen Hypotension Prediction Index, viewed August 24, 2021. https://www.accessdata.fda.gov/cdrh_docs/pdf20/K203224.pdf.
  2. Salmasi V, Maheshwari K, Yang G, Mascha EJ, Singh A, Sessler DI, et al. Relationship between intraoperative hypotension, defined by either reduction from baseline or absolute thresholds, and acute kidney injury and myocardial injury. Anesthesiology. 2017;126:47-65.
  3. Wesselink EM, Kappen TH, Torn HM, Slooter AJC, van Klei WA. Intraoperative hypotension and the risk of postoperative adverse outcomes: a systematic review. Br J Anaesth. 2018;121:706-721. doi:10.1016/j.bja.2018.04.036
  4. Shah N, Mentz G, Kheterpal S. The incidence of intraoperative hypotension in moderate to high risk patients undergoing non-cardiac surgery: A retrospective multicenter observational analysis. J Clin Anesth. 2020;66:109961. doi:10.1016/j.jclinane.2020.109961
Important safety information

Important safety information

CAUTION: Federal (United States) law restricts this device to sale by or on the order of a physician.
See Instructions For Use (IFU) / Directions For Use (DFU) for full prescribing information, including indications, contraindications, warnings, precautions and adverse events.